ARTICLE | Clinical News
Trisenox arsenic trioxide regulatory update
October 30, 2000 8:00 AM UTC
The European Commission granted Orphan Drug designation for Trisenox to treat acute promyelocytic leukemia (APL). CTIC expects to submit in the fourth quarter an MAA for European marketing approval o...